Journal of Clinical Endocrinology & Metabolism, Vol 58, 778-782, Copyright © 1984 by Endocrine Society

ARTICLES

Human platelet angiotensin II receptors: regulation by the circulating angiotensin level

TJ Moore, T Taylor and GH Williams

Human platelets possess angiotensin II (AII) receptors which increase in number in response to sodium loading, a response similar to that reported for animal smooth muscle and renal AII receptors. In these studies, we studied platelet AII binding (by Scatchard analysis of competitive binding curves) in normal subjects as they changed their dietary sodium intake from 200 to 10 to 200 meq/day. Binding capacity fell significantly after 24 h of sodium restriction and furosemide diuresis, declining to a nadir of 40% of the binding capacity found during sodium loading (from 23 to 10 fmol AII/10(9) platelets). Binding increased again after 24 h of sodium loading. There were no significant changes in receptor affinity during either low or high salt intake. The binding changes were significantly inversely correlated with the changes in plasma AII levels (r = -0.87), suggesting that AII itself is the regulator of the platelet AII receptor. Short term increases in AII level (by furosemide administration or AII infusion) did not alter platelet AII binding, indicating that the changes in platelet binding were not due simply to receptor occupancy changes. These results show that platelets have the capacity for dynamic rapid up- and down- regulated of their AII receptors and that these receptor changes are regulated by the plasma AII level.

This article has been cited by other articles:

				L. T. McGrath, L. Dixon, D. R. Morgan, and G. E. McVeigh Production of 8-epi prostaglandin F2{alpha} in human platelets during administration of organic nitrates J. Am. Coll. Cardiol., August 21, 2002; 40(4): 820 - 825. [Abstract] [Full Text] [PDF]

				G. E. McVeigh, P. Hamilton, M. Wilson, C. G. Hanratty, W. J. Leahey, A. B. Devine, D. G. Morgan, L. J. Dixon, and L. T. McGrath Platelet Nitric Oxide and Superoxide Release During the Development of Nitrate Tolerance: Effect of Supplemental Ascorbate Circulation, July 9, 2002; 106(2): 208 - 213. [Abstract] [Full Text] [PDF]

				F. Paillard, D. Chansel, E. Brand, A. Benetos, F. Thomas, S. Czekalski, R. Ardaillou, and F. Soubrier Genotype-Phenotype Relationships for the Renin-Angiotensin-Aldosterone System in a Normal Population Hypertension, September 1, 1999; 34(3): 423 - 429. [Abstract] [Full Text] [PDF]

				J. L. Dieguez-Lucena, P. Aranda-Lara, M. Ruiz-Galdon, J. Garcia-Villanova, M. Morell-Ocana, and A. Reyes-Engel Angiotensin I–Converting Enzyme Genotypes and Angiotensin II Receptors: Response to Therapy Hypertension, July 1, 1996; 28(1): 98 - 103. [Abstract] [Full Text]

				H. Shibata, H. Suzuki, T. Maruyama, and T. Saruta Gene Expression of Angiotensin II Receptor in Blood Cells of Cushing's Syndrome Hypertension, December 1, 1995; 26(6): 1003 - 1010. [Abstract] [Full Text]